AstraZeneca Reports a Stellar 7% Revenue Growth to $13.6 Billion in Q1 2025

AstraZeneca announces a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6% to $12.9 billion. The company forecasts continued growth, aiming for $80 billio...